ALBERT DAVID
|
The Current P/E Ratio of ALBERT DAVID is 72.70.
Share Price | ₹802.5 | Oct 10,2025 |
Market Cap | ₹457.4 Cr | |
Earnings-TTM | ₹6.3 Cr | TTM-Standalone Results |
Price/Earnings | 72.70x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ALBERT DAVID
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹457.4 Cr] as on Oct 10,2025
(/) Earnings [ ₹6.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 72.70x ]
Thus, for ALBERT DAVID , the investors are currently willing to pay 72.70 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALBERT DAVID !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALBERT DAVID over the last five years.
Historical PE (Price/Earnings) ratio chart of ALBERT DAVID
PE Ratio Performance Analysis for ALBERT DAVID
- ALBERT DAVID 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 12.29x.
- ALBERT DAVID 's operated at median p/e ratio of 8.61x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALBERT DAVID 's p/e ratio peaked in Mar2025 at 26.92x.
- ALBERT DAVID 's p/e ratio hit its five-year low in Mar2023 of 8.08x.
How does ALBERT DAVID 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ALBERT DAVID | 6.29 | 72.70 | 457.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 38.50 | 400,893.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 74.58 | 171,976.0 |
CIPLA LTD | 5,406.81 | 23.33 | 126,137.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 59.80 | 119,712.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.43 | 105,562.0 |
MANKIND PHARMA LTD | 1,905.51 | 53.26 | 101,491.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.55 | 99,964.3 |
LUPIN LTD | 3,722.18 | 24.05 | 89,510.8 |
AUROBINDO PHARMA LTD | 3,417.93 | 19.21 | 65,665.4 |
ABBOTT INDIA LTD | 1,452.29 | 44.15 | 64,121.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALBERT DAVID 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.43x |
Max industry PE | 74.58x |
Median industry PE | 38.50x |
Average industry PE | 40.87x |
You may also like the below Video Courses